ArticleJournal of thoracic disease2017
New insights into stage and prognosis in small cell lung cancer: an analysis of 968 cases.
Article in Journal of thoracic disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Redefining the role of surgery in early small-cell lung cancer.Langenbeck's archives of surgery · 2022Pooled it
- Pooled it
- Exercise training undertaken by people within 12 months of lung resection for non-small cell lung cancer.The Cochrane database of systematic reviews · 2019Pooled it
- Predictive modeling of peripheral blood EGFR positivity in patients with advanced primary non-small cell lung cancer.Translational lung cancer research · 2026Article
- Closing the RCT Gap-A Large Meta-Analysis on the Role of Surgery in Stage I-III Small Cell Lung Cancer Patients.Cancers · 2024Review
- Survival Analysis of Lung Cancer: A 10-Year Real-Life Experience in a Non-University-Based Hospital in Thailand (2012-2021).Asian Pacific journal of cancer prevention : APJCP · 2023Article
- Prognostic role of short-term heart rate variability and deceleration/acceleration capacities of heart rate in extensive-stage small cell lung cancer.Frontiers in physiology · 2023Article
- A Fully-Human Antibody Specifically Targeting a Membrane-Bound Fragment of CADM1 Potentiates the T Cell-Mediated Death of Human Small-Cell Lung Cancer Cells.International journal of molecular sciences · 2022Article
- Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA.Clinical cancer research : an official journal of the American Association for Cancer Research · 2021Article
- Predicting ROR1/BCL2 combination targeted therapy of small cell carcinoma of the lung.Cell death & disease · 2021Article
- Prognostic Value ofDiagnostics (Basel, Switzerland) · 2021Review
- Exploring the Role and Mechanism of pAMPKOxidative medicine and cellular longevity · 2021Article
- Immune-related adverse events on body CT in patients with small-cell lung cancer treated with immune-checkpoint inhibitors.European journal of radiology · 2020Article
- In Search of the Long-Desired 'Copernican Therapeutic Revolution' in Small-Cell Lung Cancer.Drugs · 2020Review
- Article
- A novel role mediated by adenoviral E1A in suppressing cancer through modulating decorin.Medical oncology (Northwood, London, England) · 2019Article
- Beneficial effect of additional treatment with widely available anticancer agents in advanced small lung cell carcinoma: A case report.Molecular and clinical oncology · 2018Article
- Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer.Cancer management and research · 2018Article
- Diagnostic and Prognostic Applications of PET/CT in Small-cell Lung Cancer.Cancer diagnosis & prognosisReview
- A predictive model of computed tomography and clinical features of EGFR gene mutation in lung adenocarcinoma.Science progressArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe French College of General Hospital Respiratory Physicians conducted two studies that consecutively included all patients followed in participating general hospitals for primary small cell (SCLC) or non-small cell (NSCLC) lung cancer diagnosed in 2000 and 2010. These studies allow descriptive statistics and outcome assessment for SCLC and NSCLC separately and comparison over a 10-year period.
methodsA standardised form was completed for each patient at inclusion. Then, vital status was collected.
resultsIn 2000 and 2010, 948 (15.5% female) and 968 (23.3%) SCLC patients, mainly heavy active- or former-smoker seniors, participated in these studies. One-year survival rate was 35.8% for SCLC
conclusionsOne-year survival in SCLC patients was poor in 2010 and dependent of SCLC stage. TNM classification reintroduction and new diagnostic techniques (e.g., PET-scan) should allow lung oncologists to tailor treatment based on disease stage at diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.